Physician profile
Aaron M Fields
NPI 1922061522
$6,971.95
in general payments reported to CMS, 2019-2025
46 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $988 · 2021: $1,275 · 2022: $1,105 · 2023: $1,405 · 2024: $969 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,557.47 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $689.35 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $681.05 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $675.86 | 2019-2024 | Xarelto |
| Pfizer INC. | $433.98 | 2019-2024 | |
| Glaxosmithkline, LLC. | $253.54 | 2019-2025 | Shingrix, Arexvy |
| Amgen INC. | $252.74 | 2020-2025 | Repatha, Otezla, Repatha |
| Idorsia Pharmaceuticals US INC | $219.69 | 2022-2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $219.43 | 2019-2024 | Camzyos, Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $158.99 | 2020-2023 | |
| Inspiremd Ltd | $142.86 | 2025 | Cguard Prime Carotid Stent System |
| Allergan, INC. | $129.69 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.21 | 2019-2024 | |
| Eisai INC. | $109.67 | 2020-2021 | |
| Grifols USA, LLC | $101.07 | 2019-2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.